NM_001375765.1:c.2761+6C>A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001375765.1(GIGYF1):c.2761+6C>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000686 in 1,458,622 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001375765.1 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GIGYF1 | NM_001375765.1 | c.2761+6C>A | splice_region_variant, intron_variant | Intron 24 of 26 | ENST00000678049.1 | NP_001362694.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GIGYF1 | ENST00000678049.1 | c.2761+6C>A | splice_region_variant, intron_variant | Intron 24 of 26 | NM_001375765.1 | ENSP00000503354.1 | ||||
GIGYF1 | ENST00000275732.5 | c.2761+6C>A | splice_region_variant, intron_variant | Intron 21 of 23 | 1 | ENSP00000275732.4 | ||||
GIGYF1 | ENST00000646601.1 | c.2761+6C>A | splice_region_variant, intron_variant | Intron 25 of 27 | ENSP00000494292.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.86e-7 AC: 1AN: 1458622Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 725634
GnomAD4 genome Cov.: 33
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.